Skip to main content

MoneyWorks4Me

Johnson Pharmacare - Quaterly Results

25 May 2024 Evaluate
A minor change in the total revenue was seen in the March 2024 quarter. The total revenue for the quarter stood at Rs. 0.00 millions against Rs. 0.00 millions during year ago period.The Net Loss for the quarter ended March 2024 is Rs. -0.02 millions as compared to Net Loss of Rs. -0.84 millions of corresponding quarter ended March 2023 Operating profit Margin for the quarter ended March 2024 improved to -0.02% as compared to -0.84% of corresponding quarter ended March 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 25.27 0.00 0.00 25.27 0.00
Other Income 0.00 0.00 0.00 0.00 -15.14 0.00 0.00 -15.14 0.00
PBIDT -0.02 -0.84 -97.62 -1.96 -12.91 -84.82 -1.96 -12.91 -84.82
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -0.02 -0.84 -97.62 -1.96 -12.91 -84.82 -1.96 -12.91 -84.82
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -0.02 -0.84 -97.62 -1.96 -12.91 -84.82 -1.96 -12.91 -84.82
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -0.02 -0.84 -97.62 -1.96 -12.91 -84.82 -1.96 -12.91 -84.82
Equity 550.00 550.00 0.00 550.00 550.00 0.00 550.00 550.00 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 -51.09 0.00 0.00 -51.09 0.00
Peers
Company Name CMP
Redington 346.00
Adani Enterprises 2720.00
Amrapali Industries 34.50
Maxgrow India 178.80
Rashi Peripheral 691.20
View more..